Cargando…
Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective
High‐dose BEAM chemotherapy (BCNU, etoposide, Ara‐C, and melphalan) followed by autologous hematopoietic stem cell transplantation is frequently used as consolidative therapy for patients with recurrent or refractory Hodgkin or non‐Hodgkin lymphoma. The BEAM regimen has traditionally been administer...
Autores principales: | Reid, Robin M., Baran, Andrea, Friedberg, Jonathan W., Phillips, Gordon L., Liesveld, Jane L., Becker, Michael W., Wedow, Lucy, Barr, Paul M., Milner, Laurie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119960/ https://www.ncbi.nlm.nih.gov/pubmed/27699999 http://dx.doi.org/10.1002/cam4.879 |
Ejemplares similares
-
Autologous stem cell rescue recipient with neutrophil tissue delivery detected prior to blood engraftment: A case report
por: Tbakhi, Bushra, et al.
Publicado: (2020) -
Portrait of an autologous cancer vaccine: Then and now
por: Berd, David
Publicado: (2023) -
Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States
por: Vaughn, John L., et al.
Publicado: (2021) -
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
por: Dillman, Robert O., et al.
Publicado: (2023) -
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy
por: George, Suzanne, et al.
Publicado: (2021)